JSS Barristers files Proposed Class Action Respecting Xarelto
Jensen Shawa Solomon Duguid Hawkes LLP and Siskinds LLP have launched a class action against Bayer Inc., Bayer Healthcare Pharmaceuticals Inc., Bayer Pharma AG, Janssen Pharmaceuticals, Inc., Janssen Research & Development, LLC, and Janssen Ortho LLC. in respect of the pharmaceutical drug Xarelto. Xarelto, an anti-coagulant, is touted as effective in preventing the formation of blood clots, and to lower the risk of stroke caused by a blood clot.
In the Statement of Claim, the Plaintiffs allege that Xarelto is a dangerous drug with no known antidote or reversal agent for its potentially life-threatening and even fatal side effects. The Plaintiffs allege that the Defendants knew of the risks and failed to warn the Plaintiffs, their health care providers and medical professionals of the severity of these side effects due to lack of reversal agent or antidote.
Speaking to a Lawyer
Any inquiries relating to the class action may be directed to:
Gavin Price
(403) 571-0747
priceg@jssbarristers.ca
Erin Baker
(403) 571-0744
bakere@jssbarristers.ca